Letters to the Editor
Vol. 74 No. 2 (2022)
https://doi.org/10.4081/reumatismo.2022.1491

Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 19 March 2022
Published: 13 September 2022
1407
Views
691
Downloads

Authors

F. Ceccarelli
fulvia.ceccarelli@uniroma1.it
Lupus Clinic, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
V. Covelli
Faculty of Psychology, eCampus University, Novedrate (CO), Italy.
G. Olivieri
Lupus Clinic, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
F. Natalucci
Lupus Clinic, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
C. Alessandri
Lupus Clinic, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.
F. Conti
Lupus Clinic, Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, La Sapienza University of Rome, Rome, Italy.

Not available

Downloads

Download data is not yet available.

Ceccarelli F, Covelli V, Olivieri G, et al. Systemic lupus erythematosus before and after COVID-19 lockdown: how the perception of disease changes through the lenses of narrative medicine. Healthc. 2021; 9: 726. DOI: https://doi.org/10.3390/healthcare9060726

Priori R, Pellegrino G, Colafrancesco S, et al. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021; 80: 953-4. DOI: https://doi.org/10.1136/annrheumdis-2021-220059

Watson, Clark, & Tellegen, 1988. Italian Version Terracciano, McCrae & Costa, 2003.

Wilson RS, Zwickle A, Walpole H. Developing a broadly applicable measure of risk perception. Risk Anal. 2019; 39: 777-91. DOI: https://doi.org/10.1111/risa.13207

How to Cite



1.
Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study. Reumatismo [Internet]. 2022 Sep. 13 [cited 2026 Aug. 23];74(2). Available from: https://www.reumatismo.org/reuma/article/view/1491
Copyright (c) 2022 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.